Geographic Variation in Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccine Introduction in the United States

被引:66
|
作者
Rosen, Jennifer B. [1 ,2 ]
Thomas, Ann R. [3 ]
Lexau, Catherine A. [4 ]
Reingold, Art [5 ]
Hadler, Jim L. [6 ]
Harrison, Lee H. [7 ]
Bennett, Nancy M. [8 ]
Schaffner, William [9 ]
Farley, Monica M. [10 ,11 ]
Beall, Bernard W. [1 ]
Moore, Matt R. [1 ]
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA USA
[2] Off Workforce & Career Dev, Epidem Intelligence Serv, Atlanta, GA USA
[3] Oregon Publ Hlth Div, Portland, OR USA
[4] Minnesota Dept Hlth, St Paul, MN USA
[5] Calif Emerging Infect Program, Oakland, CA USA
[6] Yale Univ, Sch Publ Hlth, Connecticut Emerging Infect Program, New Haven, CT USA
[7] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[8] Univ Rochester, Sch Med & Dent, Ctr Community Hlth, Rochester, NY USA
[9] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA
[10] Emory Univ, Dept Med, Sch Med, Georgia Emerging Infect Program, Atlanta, GA 30322 USA
[11] VA Med Ctr, Atlanta, GA USA
关键词
STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; CHANGING EPIDEMIOLOGY; SEROTYPE; CHILDREN; ERA; IMMUNIZATION; SURVEILLANCE; INFECTION; EMERGENCE;
D O I
10.1093/cid/cir326
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Rates of invasive pneumococcal disease (IPD) varied among the United States before pneumococcal conjugate vaccine (PCV7) introduction. We compared trends in IPD rates among diverse US sites over 10 years since PCV7 introduction. Methods. Patients with IPD of all ages were identified through active population and laboratory-based surveillance in 8 geographic areas under continuous surveillance during 1998-2009. Isolates were serotyped. IPD incidence rates and percent changes were calculated by site, serotype group, age, and year. Results. Reductions in rates of IPD ranged, by site, from 19 to 29.9 cases per 100,000 population during 1998-1999 to 11.2-18.0 cases per 100,000 population during 2009 (rate reduction, 5.1-15.3 cases per 100,000 population). Reductions in IPD rates among children aged < 5 years ranged from 35.7 to 117.2 cases per 100,000 population across the sites. Reductions in rates of IPD due to PCV7 serotypes were seen in all age groups at all sites, ranging from 12 to 21.4 cases per 100,000 population during 1998-1999 to < 2 cases per 100,000 population during 2009 (92%-98% reductions). Serotype 19A rates ranged from 0.4 to 1.5 cases per 100,000 population during 1998-1999 to 1.3 to 3.4 cases per 100,000 population during 2009 (rate difference, 0.9-2.8 cases per 100,000 population); modest increases were observed for most age groups across the sites. Rates of IPD due to all other serotypes ranged from 6.3 to 10.3 cases per 100,000 population during 1998-1999 to 8.3-13.6 cases per 100,000 population during 2009 (rate difference, -0.4 to 5.7 cases per 100,000 population). Across the sites, the greatest rate increases were seen in the 50-64 and > 65 year age groups. Conclusions. Reductions in IPD due to vaccine serotypes were consistent across sites. Changes in serotype 19A and all other serotypes were variable. Although relative increases in non-vaccine type serotypes were large in some sites, absolute rate increases were small.
引用
收藏
页码:137 / 143
页数:7
相关论文
共 50 条
  • [31] Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
    Knol, Mirjam J.
    Wagenvoort, Gertjan H. J.
    Sanders, Elisabeth A. M.
    Elberse, Karin
    Vlaminckx, Bart J.
    de Melker, Hester E.
    van der Ende, Arie
    EMERGING INFECTIOUS DISEASES, 2015, 21 (11) : 2040 - 2044
  • [32] Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine
    Obando, I.
    Arroyo, L. A.
    Sanchez-Tatay, D.
    Tarrago, D.
    Moreno, D.
    Hausdorff, W. P.
    Brueggemann, A. B.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (03) : 347 - 348
  • [33] The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use
    Toltzis, P
    Jacobs, MR
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2005, 19 (03) : 629 - +
  • [34] Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era
    Olarte, Liset
    Barson, William J.
    Bradley, John S.
    Tan, Tina Q.
    Lin, Philana Ling
    Romero, Jose R.
    Givner, Laurence B.
    Hoffman, Jill A.
    Hulten, Kristina G.
    Mason, Edward O.
    Kaplan, Sheldon L.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (03) : 249 - 252
  • [35] Changing Patterns of Antimicrobial Susceptibility of Invasive Pneumococcal Diseases after Introduction of Pneumococcal Conjugate Vaccine
    Nuri Bayram
    Hurşit Apa
    Gamze Gülfidan
    İlker Günay
    Nurettin Ünal
    İlker Devrim
    The Indian Journal of Pediatrics, 2014, 81 : 1124 - 1125
  • [36] Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
    Nikolova, Kristiana Alexandrova
    Andersson, Mikael
    Slotved, Hans-Christian
    Koch, Anders
    VACCINES, 2021, 9 (10)
  • [37] Changing Patterns of Antimicrobial Susceptibility of Invasive Pneumococcal Diseases after Introduction of Pneumococcal Conjugate Vaccine
    Bayram, Nuri
    Apa, Hursit
    Gulfidan, Gamze
    Gunay, Ilker
    Unal, Nurettin
    Devrim, Ilker
    INDIAN JOURNAL OF PEDIATRICS, 2014, 81 (10): : 1124 - 1125
  • [38] Invasive pneumococcal disease after implementation of 13-valent pneumococcal conjugate vaccine
    Kyprianidou, S-A.
    Mejbri, M.
    Tornay, A. A.
    Natterer, J.
    Greub, G.
    Crisinel, P-A.
    Asner, S.
    SWISS MEDICAL WEEKLY, 2014, 144 : 42S - 43S
  • [39] Impact of Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Diseases and Antibiotic Prescribing in the United Kingdom
    Gamey, Lydia E.
    Hughes, Carmel
    Lau, Wallis
    Chen, Boqing
    Karampatsas, Konstantinos
    Hsia, Yingfen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 89 - 90
  • [40] Increase in invasive pneumococcal disease in children associated with shortage of heptavalent pneumococcal conjugate vaccine
    Abuelreish, Motasem
    Subedar, Asad
    Chiu, Thomas
    Wludyka, Peter
    Rathore, Mobeen
    CLINICAL PEDIATRICS, 2007, 46 (01) : 45 - 52